The activity of Selol in multidrug-resistant and sensitive human leukemia cells

Oncology Reports

Volumn 18, Issue 4, 2007, Pages 893-899

  Suchocki, Piotr ^a,b   Misiewicz, Irena ^a   Skupinska, Katarzyna ^a   Waclawek, Karolina ^b   Fijalek, Zbigniew ^a,b   Kasprzycka Guttman, Teresa ^a  

^a National Medicine Institute   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cancer cells; Multidrug resistance; Selol

Indexed keywords

CASPASE; DOXORUBICIN; GLYCOPROTEIN P; SELENIUM DERIVATIVE; SELOL; UNCLASSIFIED DRUG; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HL 60; DRUG EFFECT; DRUG RESISTANCE; HUMAN; LEUKEMIA; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MULTIDRUG RESISTANCE; PATHOLOGY; PHENOTYPE;

APOPTOSIS; CASPASES; CELL CYCLE; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HL-60 CELLS; HUMANS; LEUKEMIA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; P-GLYCOPROTEIN; PHENOTYPE; SELENIUM COMPOUNDS; VINCRISTINE;

EID: 38449093048     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.4.893     Document Type: Article

References (23)

1. Tapiero H, Townsend DM and Tew KD: The antioxidant role of selenium and seleno-compounds. Biomed Pharmacotherapy 57: 134-144, 2003. (Pubitemid 36734802)
2. Hiraoka K, Komiya S, Hamada T, Zenmyo M and Inoue A: Osteosarcoma cell apoptosis induced by selenium. J Orthop Res 19: 809-814, 2001. (Pubitemid 32799066)
3. Ghosh J: Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of archidonate 5-lipoxygenase. Biochem Biophys Res Commun 315: 624-635, 2004.
4. 2 induces apoptosis with down-regulation of Bcl-2 and up-regulation of P53 expression in both immortal human hepatic cell line and hepatoma cell line. Mutat Res 490: 113-121, 2001.
5. Jonsson-Videsater K, Bjorkhem-Bergman L, Hossain A, Soderberg A, Eriksson LC, Paul C, Rosen A and Bjornstedt M: Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. Biochem Pharmacol 67: 513-522, 2004. (Pubitemid 38232891)
6. Bjorkhem-Bergman L, Jonsson K, Eriksson LC, Olsson JM, Lehmann S, Paul C and Bjornstedt M: Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity. Effects on thioredoxin reductase and glutathione reductase. Biochem Pharmacol 63: 1875-1884, 2002. (Pubitemid 34603452)
7. Patent (Pol. PL 176530 (Cl. A61K31/095).
8. Jastrzebski Z, Czyzewska-Szafran H, Remiszewska M, Fijalek Z, Fitak BA and Suchocki P: Effect of administration route on the dynamics of Selol absorption, distribution and elimination. Pol J Environ Stud 6 (Suppl): 64-66, 1997.
9. Jastrzebski Z, Czyzewska-Szafran H, Remiszewska M, Fijalek Z, Fitak BA and Suchocki P: Pharmacokinetics of Selol, a new agent containing selenium, in rats. Drugs Exp Clin Res 23: 7-11, 1997. (Pubitemid 27135655)
10. Zagrodzki P, Bik D, Fitak BA, Suchocki P and Niemczuk K: Selenoenzymes in animal tissues after supplementation with SELOL. Bull Vet Inst Pulawy 44: 215-220, 2000. (Pubitemid 33229224)
11. Jastrzebski Z, Czyzewska-Szafran H, Fijatek Z, Suchocki P and Fitak BA: Toxicity studies of a new selenium compound, SELOL, in rats. Drugs Exptl Clin Res 21: 217-220, 1995. (Pubitemid 26074245)
12. Marie JP, Zhou DC, Gurbuxani S, Legrand O and Zittoun R: MDR1/P-glycoprotein in haematological neoplasm. Eur J Cancer 32A: 1034-1038, 1996.
13. Borst P, Evers R, Kool M and Wijnholds J: A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92: 1295-1302, 2000. (Pubitemid 30662093)
14. Husoy T, Syversen T and Jenssen J: Comparison of four in vitro cytotoxicity tests: the MTT assay, NR assay, uridine incorporation and protein measurements. Toxic In Vitro 7: 149-154, 1993.
15. Tseng E, Scott-Ramsay EA and Morris ME: Dietary organic isothiocyanates are cytotoxic in human breast cancer MCF-7 and mammary epithelial MCF-12A cell lines. Exp Biol Med 229: 835-842, 2004. (Pubitemid 39166489)
16. Reers M, Smith TW and Chen LB: J-Aggregate formation of a carbocyanine as a quantitative fluorescent indicator of a membrane potential. Biochemistry 30: 4480-4486, 1991.
17. Hug H, Los M, Hirt W and Debatin KM: Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells. Biochemistry 38: 13906-13911, 1999. (Pubitemid 29504221)
18. McGrath T, Latoud C, Arnold ST, Safa AR, Felsted RL and Center MS: Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem Pharmacol 38: 3611-3619, 1989. (Pubitemid 19250216)
19. Marsh W, Sicheri D and Center MS: Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug. Cancer Res 46: 4053-4057, 1986. (Pubitemid 16075906)
20. Krishnamachary N and Center MS: The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658-3661, 1993. (Pubitemid 23252019)
21. Ejendal KF and Hrycyna CA: Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A. Mol Pharmacol 67: 902-911, 2005. (Pubitemid 40365337)
22. Ricci MS and Zong WX: Chemotherapeutic approaches for targeting cell death pathways. Oncologist 11: 342-357, 2006.
23. Schnaith A, Kashkar H, Leggio S, Addicks K, Kronke M and Krut O: Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J Biol Chem 282: 2695-2706, 2007. (Pubitemid 47076780)